Researcher Profile Statistics: Aguiar Bautista, José Alberto
Geo Map
Region
#
NA - North America
98
EU - Europe
74
AS - Asia, other
72
SA - South America
3
Unknown
13
Total
260
Country
#
US - United States of America
98
SG - Singapore
64
IE - Ireland
24
SE - Sweden
23
DE - Germany
18
CN - China
5
FI - Finland
3
AR - Argentina
2
CZ - Czech Republic
2
BD - Bangladesh
1
other - Other Country
20
Total
260
City
#
Dublin
22
Ashburn
18
Des Moines
14
Chandler
9
Beijing
3
Helsinki
3
Azul
2
Braunschweig
2
Clonee
2
Phoenix
2
other
183
Total
260
Most viewed items
#
Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer
64
Total
64
Most type viewed
#
patent
0
Total
0
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
7 2
1 2 6 1
0 5 2 3
9 15
53
2022
2 10
7 3 0 2
2 0 5 20
2 17
70
2023
4 3
1 2 5 0
1 1 1 3
8 11
40
2024
82 3
8 4 0 0
0 0 0 0
0 0
97
Ever
260
Geo Map
Region | # |
---|---|
NA - North America | 98 |
EU - Europe | 74 |
AS - Asia, other | 72 |
SA - South America | 3 |
Unknown | 13 |
Total | 260 |
Country | # |
---|---|
US - United States of America | 98 |
SG - Singapore | 64 |
IE - Ireland | 24 |
SE - Sweden | 23 |
DE - Germany | 18 |
CN - China | 5 |
FI - Finland | 3 |
AR - Argentina | 2 |
CZ - Czech Republic | 2 |
BD - Bangladesh | 1 |
other - Other Country | 20 |
Total | 260 |
City | # |
---|---|
Dublin | 22 |
Ashburn | 18 |
Des Moines | 14 |
Chandler | 9 |
Beijing | 3 |
Helsinki | 3 |
Azul | 2 |
Braunschweig | 2 |
Clonee | 2 |
Phoenix | 2 |
other | 183 |
Total | 260 |
Most viewed items | # |
---|---|
Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer | 64 |
Total | 64 |
Most type viewed | # |
---|---|
patent | 0 |
Total | 0 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 7 | 2 | 1 | 2 | 6 | 1 | 0 | 5 | 2 | 3 | 9 | 15 | 53 |
2022 | 2 | 10 | 7 | 3 | 0 | 2 | 2 | 0 | 5 | 20 | 2 | 17 | 70 |
2023 | 4 | 3 | 1 | 2 | 5 | 0 | 1 | 1 | 1 | 3 | 8 | 11 | 40 |
2024 | 82 | 3 | 8 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97 |
Ever | 260 |